Hamps Bio Complete Financial Statements
In FYNone, Hamps Bio (HAMPS) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of -11.1% and ROE of -12.5%. Full financial statements from FY2022 to FY2026 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse Hamps Bio ownership pattern to track promoter, FII and institutional holdings.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
HAMPS Revenue, Net Profit & EBITDA — Year-on-Year Growth
HAMPS YoY (March 2026 vs Period) — revenue -100.0%, net profit +100.0%, expenses -100.0%. For live price, earnings ratios and company overview, see HAMPS share price screener.
HAMPS Income Statement — Revenue, EBITDA & Net Profit
Hamps Bio revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin -11.1%. Also explore HAMPS share price charts to track price trends across different timeframes.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 9 | 7 | 7 | 6 | 5 |
| Expenses | 0 | 8 | 6 | 5 | 5 | 5 |
| EBITDA | 0 | 0 | 1 | 1 | 1 | 1 |
| Operating Profit Margin % | 0.00% | 1.00% | 12.00% | 18.00% | 16.00% | 12.00% |
| Depreciation | 0 | 1 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -1 | 0 | 1 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | -1 | 0 | 1 | 0 | 0 |
| Earnings Per Share (₹) | 0.00 | -0.75 | 0.68 | 2.55 | 1.34 | 0.45 |
HAMPS Balance Sheet — Assets, Liabilities & Shareholders' Equity
HAMPS total assets ₹15 Cr, total equity ₹8 Cr, total liabilities ₹ Cr (2026) — ROE -12.5%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Total Assets | 15 | 13 | 5 | 4 | 4 |
| Current Assets | 5 | 4 | 2 | 1 | 1 |
| Fixed Assets | 8 | 2 | 3 | 3 | 2 |
| Capital Work in Progress | 1 | 3 | 0 | 0 | 0 |
| Investments | 2 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 7 | 3 | 1 | 2 |
| LIABILITIES | |||||
| Total Liabilities | |||||
| Current Liabilities | 4 | 2 | 0 | 1 | 1 |
| Non-Current Liabilities | |||||
| SHAREHOLDERS' EQUITY | |||||
| Total Equity | 8 | 9 | 3 | 1 | 1 |
| Share Capital | 9 | 4 | 2 | 2 | 2 |
| Reserves & Surplus | -1 | 4 | 1 | 0 | -1 |
HAMPS Cash Flow Statement — Operating, Investing & Financing
Hamps Bio operating cash flow ₹-2 Cr, investing ₹-6 Cr, financing ₹8 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|
| Operating Activities | -2 | 0 | 1 | 0 |
| Investing Activities | -6 | 0 | -1 | 1 |
| Financing Activities | 8 | 1 | -1 | -1 |
| Net Cash Flow | 0 | 0 | 0 | 0 |